Adults with COPD who used inhaled corticosteroids for more than 24 months faced higher risks for diabetes, osteoporosis, ...

An afternoon dose also yielded significantly better overnight (10 p.m. to 4 a.m.) suppression in blood eosinophil counts as a ...

Dupilumab improved exacerbations and lung function in patients with COPD and T2 inflammation, regardless of baseline BODE index score.

Continuing our series, Dr Andrew Whittamore debunks some common myths about asthma – and explains some less well-known facts ...

Enerzair (formerly QVM149) consists of long-acting beta agonist (LABA) indacaterol, long-acting muscarinic antagonist (LAMA) glycopyrronium, and inhaled corticosteroid (ICS) mometasone furoate ...

The CRYSTAL study is the first LABA/LAMA pragmatic trial ... to Ultibro Breezhaler from other COPD treatments, such as inhaled steroid-containing combination therapies," said Vasant Narasimhan ...

Inhaled corticosteroids; LABA: Long-acting β 2-agonists; PEF: Peak expiratory flow; Pre-BD: Value measured prebronchodilator; PY: Pack-years; Raw: Airway resistance. In the last 5 years ...

LABAs and LAMAs are only used in combination with an inhaled steroid for the treatment of asthma. LABAs have a black-boxed warning for severe worsening asthma when used as monotherapy for the ...